Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 142
- Uncategorized
CANNRA Calls for Definitions and Regulations on Hemp
The Cannabis Regulators Association (CANNRA) has sent a letter to Congress outlining changes it would like to see to the 2023 Farm Bill.
- Uncategorized
Pennsylvania Medical Cannabis Growers Will Now Be Able To Sell Directly To Patients Following Senate Approval
A bill which will allow all licensed medical cannabis growers and processors in Pennsylvania to sell directly to patients has been approved by the state’s senate.
- Press releases
CB21 Pharma Successfully Extends EU GMP Certification, Reinforcing Its Position in the Pharmaceutical Industry
CB21 Pharma, a leading Czech-based pharmaceutical company specializing in producing cannabinoid ingredients and medical devices, has successfully extended its EU Good Manufacturing Practice (GMP) certification under certificate # sukls105303/2023.
- Uncategorized
Robust Rule Change for Mississippi Medical Cannabis Market
Mississippi’s Department of Health has announced a proposal for a vigorous change to its medical cannabis market’s regulations.
- Uncategorized
Five Cannabis Operators Shut Down in Oklahoma
The Oklahoma Medical Marijuana Authority (OMMA) has announced it has shut down five cannabis businesses and seized thousands of pounds of illicit cannabis.
- Uncategorized
Coalition of Cannabis Workers Says Passing SAFE Banking A ‘Moral Imperative’ Due to Worker Safety Fears
A group of 35 organisations including both NGOs and trade associations representing millions of workers in the US have called on congress to enact the long-awaited SAFE Banking Act this year.
- Opinion
Big Pharma Eyes Cannabis: The Next Frontier in High-Growth Investment
As pharma executives and life science investors navigate through a world of possibilities, the question arises: Is cannabis the high-growth sector that Pharma has been waiting for?
- Markets & Stocks
Apollon Signs New Deal To Sell Assets, New Cannabis ETF Launches After Rescheduling News, & More From Stenocare
Apollon Formularies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”APOL.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis-listed Apollon Formularies has entered into another agreement to sell its ‘global assets’ after announcing that its previous deal with Global Hemp Group (GHG) had now fallen through.
- Uncategorized
SAFE Banking Act Text Amended, Scheduled For Mark Up
The text for the SAFE Banking Act that aims to transform banking for the cannabis industry has been amended.
- Uncategorized
Mould Testing on Cannabis Products suspended in Oregon
The Oregon Health Authority (OHA) has filed a temporary suspension on the testing of cannabis products for the mould Aspergillus.
- Uncategorized
BZAM has ‘Significantly Improved Margins’ Since Merger as Hundreds of Jobs Lost and Numerous Sites Sold
Canadian cannabis producer BZAM says it has managed to cut annual costs by $20m since its merger with The Green Organic Dutchman last year.
- Events
Big Tobacco Wants ‘Meaningful Part’ In Cannabis Industry: Key Insights from the Cannabis Business Expo 2023
Cannabis industry stakeholders from across the world were welcomed to Messe Dortmund this week for the inaugural edition of the Cannabis Business Expo 2023.
